Think bigger when measuring remote monitoring effects
Remote monitoring studies are missing the mark when assessing the value of the technology. Here’s why.
The highly publicized and disappointing results of two recent controlled trials on the effectiveness of mobile health and telemonitoring have shaken the digital health movement.
BilodeauStudy #1: This study, released in
Study #2: This study, released in
So what's going on here? Have the digital health hypemeisters sold us a bill of goods?
Each study sought to find out if the addition of remote monitoring technology reduced costs or improved outcomes beyond the baseline program. That should be the focal purpose of any intervention, including telemonitoring, right?
Wrong, and here’s why.
SchmulandWe know that the experiences, exposures, habits, and social forces of life are critical determinants of health and recovery, and in many cases are more powerful than what happens inside the patient and care facilities. But the outside-the-facility outreach programs that work best for managing patients with chronic disease today (such as telemonitoring programs like those studied above) are costly and labor intense because they require nurse case managers and interdisciplinary care teams-which explains why the cost-benefits of chronic disease management programs have, so far, been elusive.
Internal server error